Q1 FY27 snapshot
Announcement Date6-Aug-26
Revenue (Top Line)₹9414.58 Cr
Net Profit (Bottom Line)₹1032.56 Cr
Earnings Per Share (EPS)₹17.78
Expenses₹7271 Cr
Net profit margin (calculated)11%
Aurobindo Pharma Ltd. (AUROPHARMA) Quarterly Results: Q1 FY27
Quick answer: Aurobindo Pharma Ltd. (NSE: AUROPHARMA) reported Q1 FY27 revenue of ₹9414.58 Cr and net profit of ₹1032.56 Cr, with earnings per share (EPS) of ₹17.78, announced on 6-Aug-26.
That works out to a net profit margin of about 11% for the quarter.
Note: figures are pulled automatically from company filings and may lag or contain gaps. Verify on NSE or BSE. Not investment advice.
How to read Aurobindo Pharma Ltd.'s Q1 FY27 results
Revenue of ₹9414.58 Cr is what Aurobindo Pharma Ltd. earned before costs. Net profit of ₹1032.56 Cr is what remained for shareholders after expenses, interest and tax. Dividing one by the other gives a net margin of about 11%, a quick gauge of how much of each rupee of sales is kept as profit.
New to results? Read our guide on how to read quarterly results, see the full results list or the dividend calendar.
FAQs
Aurobindo Pharma Ltd. results FAQs
What were Aurobindo Pharma Ltd.'s Q1 FY27 results?
Aurobindo Pharma Ltd. (NSE: AUROPHARMA) reported Q1 FY27 revenue of ₹9414.58 Cr and net profit of ₹1032.56 Cr, with earnings per share (EPS) of ₹17.78, announced on 6-Aug-26.
What is Aurobindo Pharma Ltd.'s EPS for Q1 FY27?
Aurobindo Pharma Ltd.'s earnings per share for Q1 FY27 was ₹17.78. EPS is net profit divided by the number of outstanding shares.
When did Aurobindo Pharma Ltd. announce its Q1 FY27 results?
Aurobindo Pharma Ltd. announced its Q1 FY27 results on 6-Aug-26.
What is Aurobindo Pharma Ltd.'s net profit margin?
On the reported figures, Aurobindo Pharma Ltd.'s Q1 FY27 net profit margin is about 11% (net profit ÷ revenue).